Elena Ratner
- Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments 31
- Uterine Myomas and Treatments 22
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 47
- Endometriosis Research and Treatment 11
- Oncology top 2%
- HER2/EGFR in Cancer Research 22
- PARP inhibition in cancer therapy 14
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 9
- Pathology and Forensic Medicine top 10%
-
- Monoclonal and Polyclonal Antibodies Research 12
- Co-authors
- Peter E. SchwartzAlessandro D. SantinMasoud AzodiThomas RutherfordStefania BelloneNatália BuzaDan‐Arin SilasiZ. Ping Lin
- Journals
- Gynecologic Oncology (35 papers)International Journal of Gynecological Cancer (9 papers)Journal of Clinical Oncology (8 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Elena Ratner
137 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 119
- Obstetrics and Gynecology 679
- Reproductive Medicine 622
- Oncology 1.0k
- Cancer Research 294
- Pathology and Forensic Medicine 190
Countries citing papers authored by Elena Ratner
This map shows the geographic impact of Elena Ratner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Ratner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Ratner more than expected).
Fields of papers citing papers by Elena Ratner
This network shows the impact of papers produced by Elena Ratner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Ratner. The network helps show where Elena Ratner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elena Ratner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 4 | |
| 8 | 2021 | 14 | |
| 9 | 2020 | 6 | |
| 10 | 2018 | 35 | |
| 11 | 2018 | 6 | |
| 12 | 2018 | 20 | |
| 13 | 2018 | 28 | |
| 14 | 2017 | 15 | |
| 15 | 2016 | 30 | |
| 16 | 2015 | 26 | |
| 17 | 2015 | 26 | |
| 18 | 2014 | 34 | |
| 19 | 2013 | 3 | |
| 20 | The KRAS-Variant Genetic Test As a Marker of Increased Risk of Ovarian Cancer. | 2010 | 5 |
About Elena Ratner
Elena Ratner is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 145 papers that have together received 2.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (47 papers), Endometrial and Cervical Cancer Treatments (31 papers), HER2/EGFR in Cancer Research (22 papers), Uterine Myomas and Treatments (22 papers), PARP inhibition in cancer therapy (14 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Endometriosis Research and Treatment (11 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Obstetrics and Gynecology (679 citations), Reproductive Medicine (622 citations) and Oncology (1.0k citations). Elena Ratner has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Peter E. Schwartz, Alessandro D. Santin, Masoud Azodi, Thomas Rutherford, Stefania Bellone, Natália Buza, Dan‐Arin Silasi, Z. Ping Lin, Mary Jane Minkin and Emiliano Cocco. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.